Exits

PORTFOLIO

BioStar Capital invests in and nurtures transformative medical technologies. We have consistently produced life-changing outcomes for patients and rewarding returns for investors.

Active

Exits

Definitive Agreement to be Acquired by Stryker Corp. (NYSE: SYK).

Acquired by Hansen Medical (NASDAQ: HNSN).

Acquired by Boston Scientific Corporation (NYSE: BSX).

Acquired by Medtronic (NYSE: MDT).

Acquired by Zimmer Biomet (NYSE: ZBH).

Acquired by Siemens Healthineers for $1.1 billion.

Acquired by Covidien (NYSE: COV).

Acquired by NuVasive, Inc. (NASDAQ: NUVA).

Acquired by Edwards Lifesciences Corp. (NYSE: EW).

Acquired by Teleflex Incorporated (NYSE: TFX).

Acquired by Endologix, Inc. (NASDAQ: ELGX).

Acquired by Stryker Corp. (NYSE: SYK).

Acquired by Boston Scientific Corporation (NYSE: BSX).

Acquired by Covidien (NYSE: COV).

Sale of public stock (NASDAQ: SENS).

Acquired by Medtronic (NYSE: MDT).